Submitted:
09 January 2026
Posted:
14 January 2026
You are already at the latest version
Abstract

Keywords:
1. Introduction
2. Methods
2.1. Theoretical Framework: The Prevention Theorem
2.2. Closed-Form Prevention Solution
2.3. Infection Establishment Dynamics
2.4. Master Equation for Time-Dependent Prevention
3. Results
3.1. Visualization of the Theorem
3.2. Finite Prevention Window for Post-Exposure Prophylaxis
3.3. Irreducible Infection State
3.4. Reservoir Stratification
3.5. Applied Example: Structural Infeasibility Under Access Delays
4. Discussion
4.1. Theoretical Implications
4.2. Biological Proof of Concept: CCR5-Δ32
4.3. Implications for Epidemic Control
5. Future Work
Data Sharing
Declaration of Interests
Ethics Approval and Consent to Participate
Acknowledgments
Use of Artificial Intelligence and Assistive Technologies
References
- Grant, R. M. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine 2010, 363(27), 2587–2599. [Google Scholar] [CrossRef] [PubMed]
- Anderson, P. L. Emtricitabine–tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Science Translational Medicine 2012, 4(151), 151ra125. [Google Scholar] [CrossRef] [PubMed]
- Blower, S. M.; Dowlatabadi, H. Sensitivity and uncertainty analysis of complex models of disease transmission: An HIV model as an example. International Statistical Review 1994, 62(2), 229–243. [Google Scholar] [CrossRef]
- McMichael, A. J.; Rowland-Jones, S. L. The immune response to HIV. Immunity 2010, 33(4), 431–441. [Google Scholar]
- Wahl, L. Al-Harthi, HIV infection of non-classical cells in the brain. Retrovirology 2023, 20(1), 1. [Google Scholar] [CrossRef] [PubMed]
- Siliciano, J. D.; Siliciano, R. F. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells. Methods in Molecular Biology 2015, 1354, 3–15. [Google Scholar]
- Greenhalgh, D.; Hay, G. Mathematical modelling of the spread of HIV/AIDS amongst injecting drug users. IMA Journal of Mathematics Applied in Medicine and Biology 1997, 14(1), 11–38. [Google Scholar] [CrossRef] [PubMed]
- Liang, Y.; Greenhalgh, D.; Mao, X. A Stochastic Differential Equation Model for the Spread of HIV amongst People Who Inject Drugs. Computational and Mathematical Methods in Medicine 2016, 2016, 1–14. [Google Scholar] [CrossRef] [PubMed]
- Grant. Evidence for Early Central Nervous System Involvement in the Acquired Immunodeficiency Syndrome (AIDS). Annals of Internal Medicine 1987, 107(6), 828–836. [Google Scholar] [CrossRef] [PubMed]
- Tanner, M. R. Antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV – CDC recommendations, United States, 2025. MMWR Recomm Rep 2025, 74(1), 1–56. [Google Scholar] [CrossRef] [PubMed]
- Strathdee, S. A. Preventing HIV outbreaks among people who inject drugs in the United States: plus ça change, plus c'est la même chose. AIDS 2020, 34(14), 1997–2005. [Google Scholar] [CrossRef] [PubMed]
- Brown, T. R.; Castillejo, A. Long-term follow-up of the London patient—the second adult to be cured of HIV-1 infection. Lancet HIV 2019, 6(12), e821–e829. [Google Scholar]
- Hutter, G. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell-derived grafted dendritic cells. New England Journal of Medicine 2009, 360(7), 692–698. [Google Scholar] [CrossRef]
- Anderson, A. M. Neuroinflammation in HIV: The role of translocator protein. Journal of Neurovirology 2020, 26(6), 768–786. [Google Scholar]
- Hellmuth. Very early initiation of antiretroviral therapy during acute HIV infection is associated with normalized levels of immune activation markers in cerebrospinal fluid. Journal of Infectious Diseases 2018, 220(2), 208–213. [Google Scholar] [CrossRef] [PubMed]
- Taylor, L.; Walley, A. Y.; Bazzi, A. R. Stuck in the window with you: HIV exposure prophylaxis in the highest risk people who inject drugs. Substance Abuse 2019, 40(4), 441–443. [Google Scholar] [CrossRef] [PubMed]
- Baugher, R. Are we ending the HIV epidemic among persons who inject drugs? Key findings from 19 US cities. AIDS 2025, 39(12), 1813–1819. [Google Scholar] [CrossRef] [PubMed]
- Palella, F. J. J. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine 1998, 338(13), 853–860. [Google Scholar] [CrossRef] [PubMed]


Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).